![John Higgons](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Higgons
Presidente presso
Akamis Bio Ltd.
Profilo
John Duncan Higgons is currently Chairman at Akamis Bio Ltd. and Director at Rheos Medicines, Inc. Formerly, Mr. Higgons was Director at Aras Corp., Independent Director at Jounce Therapeutics, Inc. from 2015 to 2022, Director at Auron Therapeutics, Inc., SVP-Marketing & Business Development at Alkermes, Inc., SVP-Business Development & Marketing at Eli Lilly & Co., Executive Vice President-Business Operations at Archemix Corp.
from 2006 to 2009, Chief Operating Officer at Agios Pharmaceuticals, Inc. from 2009 to 2016, and Chief Commercial Officer at TransForm Pharmaceuticals, Inc. Education includes graduate studies at London Business School and undergraduate studies at King's College London.
Posizioni attive di John Higgons
| Società | Posizione | Inizio |
|---|---|---|
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Presidente | - |
Rheos Medicines, Inc.
 Rheos Medicines, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease | Direttore/Membro del Consiglio | 10/10/2018 |
Precedenti posizioni note di John Higgons
| Società | Posizione | Fine |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 31/12/2022 |
| AGIOS PHARMACEUTICALS, INC. | Direttore operativo | 15/01/2016 |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Provides molecular biology research to develop new drugs | Amministratore Delegato | - |
Auron Therapeutics, Inc.
 Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells | Direttore/Membro del Consiglio | - |
Aras Corp.
 Aras Corp. Packaged SoftwareTechnology Services Develops an application platform for product lifecycle management | Direttore/Membro del Consiglio | - |
Formazione di John Higgons
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
61
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Provides molecular biology research to develop new drugs | Commercial Services |
Aras Corp.
Aras Corp. Packaged SoftwareTechnology Services Develops an application platform for product lifecycle management | Technology Services |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Health Technology |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Rheos Medicines, Inc.
Rheos Medicines, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease | Health Technology |
Auron Therapeutics, Inc.
Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells | Commercial Services |
